High carrier prevalence of deficient and null alleles of CYP2 genes in a major USA hospital: implications for personalized drug safety

By Ruaño Gualberto   Makowski Greg   Windemuth Andreas   Kocherla Mohan   Weiss Stephen   Goethe John W   Bower Bruce   Wu Alan HB   Thompson Paul D  

Personalized Medicine, Vol. 3, Iss. 2, 2006-05 ,pp. : 131-137

Future Medicine

Access to resources Recommend Favorite

Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 3, 2018-03 ,pp. : 510-519

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevalence of CYP2C19 alleles, pharmacokinetic and pharmacodynamic variation of clopidogrel and prasugrel in Bangladeshi population

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 5, 2015-05 ,pp. : 451-457

John Wiley & Sons Inc

Access to resources Recommend Favorite

High carrier prevalence of combinatorial CYP2C9 and VKORC1 genotypes affecting warfarin dosing

By Ruañño Gualberto   Thompson Paul D   Villagra David   Bower Bruce   Kocherla Mohan   Yazdanpanah Golriz   Seip Richard L   Windemuth Andreas   White C Michael   Duconge Jorge   Holford Theodore R   Wu Alan HB  

Personalized Medicine, Vol. 5, Iss. 3, 2008-05 ,pp. : 225-232

Future Medicine

Access to resources Recommend Favorite

Variant VKORC1 and CYP2C9 Alleles in Patients with Diffuse Alveolar Hemorrhage Caused by Oral Anticoagulants

By Wijnen Petal A.   Linssen Catharina F.   Haenen Guido R.   Bekers Otto   Drent Marjolein  

Molecular Diagnosis & Therapy, Vol. 14, Iss. 1, 2010-02 ,pp. : 23-30

Adis International

Access to resources Recommend Favorite